| Autor: |
Glodzik D; Wellcome Trust Sanger Institute, Cambridge, UK., Morganella S; Wellcome Trust Sanger Institute, Cambridge, UK., Davies H; Wellcome Trust Sanger Institute, Cambridge, UK., Simpson PT; The University of Queensland: UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, Australia., Li Y; Wellcome Trust Sanger Institute, Cambridge, UK., Zou X; Wellcome Trust Sanger Institute, Cambridge, UK., Diez-Perez J; Wellcome Trust Sanger Institute, Cambridge, UK., Staaf J; Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden., Alexandrov LB; Wellcome Trust Sanger Institute, Cambridge, UK.; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, New Mexico, USA.; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico, USA., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands., Brinkman AB; Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands., Rye IH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norwegian Radiumhospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Russnes H; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norwegian Radiumhospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Raine K; Wellcome Trust Sanger Institute, Cambridge, UK., Purdie CA; Department of Pathology, Ninewells Hospital &Medical School, Dundee, UK., Lakhani SR; The University of Queensland: UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland, Australia.; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia., Thompson AM; Department of Pathology, Ninewells Hospital &Medical School, Dundee, UK.; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Birney E; European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridgeshire, UK., Stunnenberg HG; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands., van de Vijver MJ; Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, the Netherlands., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norwegian Radiumhospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kong G; Department of Pathology, College of Medicine, Hanyang University, Seoul, South Korea., Viari A; Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France.; Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France., Easton D; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Evan G; Department of Biochemistry, University of Cambridge, Cambridge, UK., Campbell PJ; Wellcome Trust Sanger Institute, Cambridge, UK., Stratton MR; Wellcome Trust Sanger Institute, Cambridge, UK., Nik-Zainal S; Wellcome Trust Sanger Institute, Cambridge, UK.; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. |
Full text from SpringerLink